IQVIA AI Assistant Wins 2024 PM360 Innovation Award for Artificial Intelligence
RESEARCH TRIANGLE PARK, N.C. – February 24, 2025 – IQVIA (NYSE:IQV), a prominent international provider of advanced analytics, tech solutions, and clinical research services for the life sciences and healthcare industries, today announced its IQVIA AI Assistant has been honored with a 2024 PM360 Innovation Award in the Artificial Intelligence category.
Launched in September 2024, the IQVIA AI Assistant transforms the way insights are generated. It rapidly provides precise and relevant answers to complex business questions. Using a conversational interface and sophisticated data science, it makes complex analytics accessible to a wide range of users, delivering near real-time insights.
IQVIA AI Assistant builds upon IQVIA’s substantial experience in artificial intelligence and its development of Healthcare-grade AI™. This AI is a proven and trusted foundation built with data privacy, security, and regulatory compliance at its heart. Healthcare-grade AI represents IQVIA’s commitment to responsible AI use. Its AI-powered capabilities are built on best-in-class approaches to privacy, regulatory compliance, and patient safety. It delivers AI to the high standards of trust, scalability, and precision expected by the industry.
“We are delighted to have won an Innovation Award from PM360 for IQVIA AI Assistant. This recognition highlights how the IQVIA AI Assistant is changing how healthcare and life sciences customers obtain crucial insights,” said Bhavik Patel, president of Commercial Solutions, IQVIA. “This is what IQVIA Healthcare-grade AI is all about — delivering the benefits of AI while maintaining the quality, precision, and trust we all expect.”
IQVIA Orchestrated Analytics with AI Assistant and IQVIA ChannelDynamics® Verbatim with AI Assistant are currently available, with additional offerings planned for launch this year. These solutions empower life sciences companies to seamlessly integrate AI-driven insights into their strategic decision-making processes. Companies can enhance the precision and efficiency of key life sciences programs, such as commercial analytics and market research.
PM360 is a publication providing comprehensive information for pharmaceutical brand managers and marketing professionals to succeed in their roles. The PM360 Innovation Awards recognize the most innovative companies, products, services, and strategies in the life sciences industry. The AI category focuses on AI/ML companies or products that are helping to improve processes within healthcare and the life sciences, including marketing.
For more information about the IQVIA AI Assistant and other IQVIA solutions, visit www.iqvia.com.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions is powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built using high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies, and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance, and patient safety. It delivers AI to the high standards of trust, scalability, and precision demanded by the industry.
With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology, and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments. This helps improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect personal privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate them with the precise treatment path and therapy needed for better outcomes.
IQVIA’s insights and execution capabilities help biotech, medical device, and pharmaceutical companies, medical researchers, government agencies, payers, and other healthcare stakeholders gain a deeper understanding of diseases, human behaviors, and scientific advances. This assists these stakeholders in advancing their path toward cures.
To learn more, visit www.iqvia.com.
Contacts: Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com) +1.973.541.3558
Alissa Maupin, IQVIA Media Relations (alissa.maupin1@iqvia.com) +1.919.923.6785
